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Summary 
Background: The mutant CCR5D32 allele confers resist-
ance to HIV infection. Several hypotheses regarding its ori-
gin and persistence in the human population have been
proposed. It is assumed that the D32 mutation was intro-
duced in Northern or Eastern Europe and that it spread to
the south. Although the frequency of CCR5D32 was deter-
mined in numerous European nations and regions, further
data are needed to complete the puzzle of CCR5D32 dis-
tribution within the continent. 
Methods: To this end, CCR5D32 frequency was determined
in a Serbian population (sample size 352). DNA was
extracted from peripheral whole blood and polymerase
chain reaction specific for CCR5 gene was performed. A
reaction product of 263 bp was obtained from the wild-
-type CCR5 sequence and a product of 231 bp was ob -
tain ed from the truncated CCR5D32 sequence. 
Results: Overall allele frequency of CCR5D32 is 4.55%;
0.57% of individuals in the examined population are homo -
zygous and 8.52% are heterozygous for CCR5D32. 
Conclusions: The determined frequency of the CCR5D32
allele in a Serbian population is unexpectedly low, consi d -
ering ethnically related populations.
Keywords: CCR5, D32, Serbia
Kratak sadr`aj
Uvod: Nosioci alela CCR5D32 su relativno rezistentni na
infekciju HIV-om. Postoji nekoliko hipoteza o poreklu i
odr`anju ovog alela u ljudskoj populaciji. Pretpostavlja se da
je mutacija D32 nastala u populaciji severne ili isto~ne
Evrope i da se potom pro{irila ka jugu. Iako je u~estalost
CCR5D32 odre|ena u mnogim evropskim populacijama,
dodatni podaci su neophodni za formiranje sveobuhvatne
slike o distribuciji CCR5D32 u Evropi. Zbog toga smo u
na{oj studiji odredili u~estalost CCR5D32 u srpskoj popu-
laciji, za koju do ovog rada nisu postojali takvi podaci. 
Metode: DNK je izolovana iz periferne krvi 352 osobe. U
reakciji lan~anog umno`avanja kori{}eni su prajmeri spe -
cifi~ni za gen CCR5. Dobijen je proizvod od 263 bp na
osno vu matrice »wild type«, sekvence CCR5 gena, a pro iz -
vod od 231 bp na osnovu okrnjene sekvence gena CCR5
(CCR5D32). Ukupna u~estalost alela CCR5D32 u srpskoj
populaciji iznosi 4,55%. 
Rezultati: Od ukupnog broja analiziranih osoba, identifiko-
vano je 8,52% heterozigotnih i 0,57% ho mo zigotnih nosila-
ca za ovaj alel. 
Zaklju~ak: Utvr|ena u~es talost alela CCR5D32 u srpskoj
populaciji je neo~ekivano niska, u pore |enju sa u~estalo{}u
u ostalim slovenskim populacijama. 
Klju~ne re~i: CCR5, D32, Srbija
List of non-standard abbreviations: AIDS, acquired immuno -
deficiency syndrome; bp, base pair; CFTR, cystic fibrosis
transmembrane conductance regulator; HIV, human immu no -
deficiency virus; n, number; PCR, polymerase chain reaction;
SD, standard deviation.
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Introduction
Chemokines and their receptors have an essen-
tial role in directing cell migration during develop-
ment and in immunity. However, viruses and other
pathogens are able to produce chemokine-like and
chemokine receptor-like molecules and to modulate
the immune response directed against them (1). As
an extreme example, human immunodeficiency virus
(HIV) uses chemokine receptors as co-receptors to
enter human cells. The most prominent co-receptors
for HIV entry into cells are CCR5 and CXCR4 (2).
CCR5 is the major co-receptor during primary infec-
tion. Importantly, the CCR5 gene is polymorphic and
the CCR5D32 allele is linked to HIV restriction, viral
control, and progression to acquired immunodefi-
ciency syndrome (AIDS) (2). The CCR5D32 allele has
a 32-base pair deletion within exon 3 in comparison
to the wild type allele. Out of these 32 base pairs, 20
base pairs are missing in the coding sequence.
Consequently, an mRNA frameshift occurs which cre-
ates a stop codon and leads to generation of the trun-
cated CCR5 protein. In this way, HIV binding to CCR5
and entrance of the virus into cells is prevented (2, 3).
Hence, homozygotes for the CCR5D32 allele exhibit
a strong, yet incomplete resistance to HIV infection,
while heterozygotes show delayed progression to
AIDS (3).
The CCR5D32 allele appeared in the European
po pulation long before the HIV epidemic. Libert et al.
(4) hypothesized that the allele originated in North -
eastern Europe and spread towards the south of the
continent. An alternative assumption came from Ba -
la novsky et al. who suggested that the allele emerged
among Uralic-speaking populations and that its fre-
quency increased in Northeastern Europe as a result
of positive selection and/or genetic drift (5). Accor -
ding to this group, secondary spread and selection
occurred due to gene flow and migrations. This sec-
ondary spread might have been performed by Vi -
kings, as suggested by Lucotte (6). Selective pressure
has mainly been attributed to infectious diseases. One
of the major candidates has been the bubonic plague
that swept across the Europe in the 14th century and
killed up to a third of its population (7). However, sim-
ilar frequency of the CCR5D32 allele was determined
in ancient DNA samples from individuals that died
from bubonic plague and control subjects, arguing
against the plague as the selective factor for the allele
persis tence (8). Other suspected diseases include viral
hemo rrhagic fever (9) and smallpox (10). Stephens et
al. (7) suggested that the allele originated in the
European population some 700 years ago, while
more recent genetic mapping and studies on ancient
DNA indicate that the allele might have been present
in human populations for 3–7 thousand years (11).
Accordingly, relatively high frequency of the
CCR5D32 allele was found in ancient DNA samples
from medieval Poland (12). Further, the allele was iso-
lated from ancient DNA samples from Bronze Age
skeletons found in central Germany and southern
Italy (13). Importantly, linkage disequilibrium in the
CCR5 region is similar to other human genomic
regions, which along with the extent of heterozygosi-
ty and differentiation across populations challenges
the hypotheses of recent positive selection of the
CCR5D32 allele (11). Additionally, Faure and Royer-
Carenzi (14) have proposed that the allele has not
been positively selected, but rather present at low fre-
quency due to the yet unknown zoonosis spread from
Mediterranean civilizations northward. If immune de -
fense against such zoonosis is dependent on an intact
CCR5 protein, individuals carrying a truncated form
of CCR5D32 would be vulnerable to the disease. Al -
though individuals homozygous for CCR5D32 show
no obvious immunodeficiency, it has recently been
reported that this allele is a risk factor for both early
and late clinical manifestations of the West Nile virus
infection (15, 16). Alternatively, there are hypotheses
that the frequency of CCR5D32 has been influenced
by climatic or geographical factors (5, 17).
Here, the frequency of the mutant CCR5D32
allele was analyzed in a Serbian population for the
first time. Relatively low frequency of the allele in
comparison to other Slavic populations was detected.
Materials and Methods
Population
According to previously published data on the
frequency of CCR5D32 in populations neighboring
Serbia, ranging from less than 4% in Greece and
exceeding 8% in Hungary (6, 7, 14), it was assumed
that the frequency of the allele in a Serbian popula-
tion would be 6.0 +/–2.5 %. Subsequently, a sample
size of 350 was estimated to have a 95% confidence
level, as calculated from the following formula:
where n is sample size, z is critical value for the con-
fidence level, m is margin of error, p is the supposed
proportion of allele. Thus, we examined 352 resi-
dents of Serbia in our study. Basic data about the pop -
ulation are as follows: 219 females and 133 males,
age (mean +/– SD) 38.9+/–13.3 years, age median
37.0 years, age range 1–83 years.
DNA isolation and amplification
DNA was extracted from peripheral whole blood
using GFX Genomic Blood DNA Purification kits (GE
Healthcare, Little Chalfont, UK). Polymerase chain
reactions were performed in a 25 mmol/L containing:
2 mL of dsDNA template (∼100 ng), 2.5 mL of 10X
Taq buffer with (NH4)2SO4, 2.5 mL of 25 mmol/L
MgCl2, 0.2 mL of 25 mM dNTP mix, 1 mL of 10
n ≥ z_ × p(1–p)m( )
2
370 \or|evi} et al.: CCR5D32 frequency in Serbia
mmol/L forward primer (5’-CCC AGG AAT CAT CTT
TAC CAG-3’) to a final concentration of 0.5 mmol/L,
1 mL of 10 mmol/L reverse primer (5’-CCC AGA AGA
GAA AAT AAA CAA TCA T-3’) to a final concentra-
tion of 0.5 mmol/L, 0.2 mL of 5 U/mL Taq polymerase
(Ther mo Scientific, Waltham, MA) and 15.6 mL of
water. The polymerase chain reaction was performed
in Thermocycle T1 (Bio metra, Jena, Germany). After
initial denaturation at 95 °C for 5 min, the amplifica-
tion was performed for 40 cycles under the condi-
tions: 95 °C for 30, 60 °C for 30 and 72 °C for 1 min.
Electrophoresis of samples was performed in 1%
agarose gel and PCR products were visualized by
ethidium-bromide staining. A PCR product of 263
bp was obtained from the wild-type CCR5 sequence
and a PCR product of 231 bp was obtained from the
truncated CCR5D32 sequence (Figure 1).
Statistical analysis
To determine the statistical significance of the
difference between the frequency of CCR5D32 allele
in the Serbian population and other European pop -
ulations, a two-tailed (H0: p1=p2; Ha: p1≠p2) differ-
ence of proportions z-test was performed (p<0.05
was considered statistically significant).
Results and Discussion
Out of 352 analyzed samples, there were two
homozygous and 30 heterozygous for the CCR5D32
allele. Thus, 0.57% of individuals in the examined
population were homozygous and 8.52% were het-
erozygous for CCR5D32. Overall frequency of the
CCR5D32 allele in the Serbian population was
4.55%. We further determined if this frequency is sig-
nificantly different to the frequency of CCR5D32 alle -
le in other European populations. We had to exclude
some of the published data about the CCR5D32
allele frequency (e.g. Austria and Romania) from our
analysis, as their sample size was not big enough for
the test applied. Results of the analysis are shown in
Table I.
The determined frequency of the CCR5D32
allele in the Serbian population is the lowest observed
among Slavic populations. The closest proportion of
the allele was observed in a Bulgarian population that
is geographically closest to Serbia (East–West direc-
tion), but with a strong ethnic influence of non-Slavic
origin. With Croats, however, who are also close by to
Serbs (West–East direction), the difference is larger
(Figure 2). On the other hand, similar frequencies of
the CCR5D32 allele were observed in Greece and Ro -
mania which are ethnically distant, yet geographically
close to Serbia. However, similar frequencies were
determined in both ethnically and geographically dis-
tant populations (Italy, some parts of Spain and
Portugal), as well as in Crimea whose population is
ethnically closer to the Serbian. 
The observed discrepancy in the CCR5D32
allele frequency in Serbian and neighboring popula-
tions or ethnically close populations is not an isolated
phenomenon. For instance, it was previously reported
that the frequency of mutations of the gene encoding
the cystic fibrosis transmembrane conductance regu-
Figure 1 Electrophoresis profile of PCR products obtained with CCR5 amplifying primers. Representative samples are shown.
DNA ladder scale is in bp.
Figure 2 Multicolor representation of CCR5D32 allele fre-
quency in Europe. This hypothetic distribution of the allele
frequency was made according to data shown in Table I and
additional data for Austria and Romania that due to low sam-
ple size were not included in Table I (Faure et al., 2008). For
countries with more than one piece of data, approximations
were made for mean frequency. In most cases country
boundaries were respected, except for major European
islands and Crimea peninsula.
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Country city, region, nation frequency z Reference
Cyprus Greeks 0.027 1.782 Faure et al. 2008
Italy Sardinia 0.027 1.563 Faure et al. 2008
France Corsica 0.032 0.899 Faure et al. 2008
Greece Crete 0.032 0.892 Faure et al. 2008
Spain Sevilla 0.038 0.395 Faure et al. 2008
Greece 0.039 0.542 Faure et al. 2008
Italy Sicily 0.040 0.439 Faure et al. 2008
Greece Athens 0.041 0.171 Magierowska et al. 1998
Greece Greeks 0.044 0.086 Stephens et al. 1998
Serbia 0.046 0.000
Italy Italians 0.047 –0.140 Faure et al. 2008
Italy Padua 0.047 –0.024 Faure et al. 2008
Spain San Sebastian 0.050 –0.191 Magierowska et al. 1998
Ukraine Crimea 0.050 –0.402 Faure et al. 2008
Bulgaria 0.051 –0.112 Faure et al. 2008
France Nice 0.052 –0.134 Faure et al. 2008
Portugal Porto 0.052 –0.134 Faure et al. 2008
Turkey 0.054 –0.320 Faure et al. 2008
Italy Italians 0.055 –0.346 Stephens et al. 1998
Italy Rome 0.057 –0.735 Faure et al. 2008
Spain Basques 0.062 –0.850 Stephens et al. 1998
Turkey Turks 0.063 –0.895 Libert et al. 1998
Portugal Lisbon 0.064 –0.575 Faure et al. 2008
Portugal Portuguese 0.064 –0.575 Libert et al. 1998
Croatia Island of Rab, Lopar 0.065 –0.640 Faure et al. 2008
France Perpignan 0.068 –0.940 Faure et al. 2008
Spain Basques 0.068 –0.954 Faure et al. 2008
Croatia 0.071 –1.482 Faure et al. 2008
Spain Spanish 0.073 –1.030 Faure et al. 2008
Spain Catalonia 0.074 –1.360 Faure et al. 2008
Slovenia Slovenians 0.077 –1.125 Stephens et al. 1998
Sweden Lapland 0.080 –1.571 Faure et al. 2008
Albania 0.082 –1.289 Faure et al. 2008
Ireland 0.083 –1.810 Faure et al. 2008
Slovenia 0.083 –2.140 Faure et al. 2008
Sweden Saamis 0.083 –1.571 Libert et al. 1998
Switzerland Bern 0.085 –1.098 Faure et al. 2008
Hungary Hungarians 0.086 –1.746 Libert et al. 1998
France Reims 0.087 –2.114 Faure et al. 2008
Italy Milano 0.087 –1.773 Libert et al. 1998
Italy Milan 0.087 –1.773 Faure et al. 2008
France French 0.089 –2.032 Faure et al. 2008
France French 0.089 –2.032 Stephens et al. 1998
Ukraine Lugansk 0.090 –1.738 Faure et al. 2008
Finland Finns 0.091 –2.174 Stephens et al. 1998
Belgium Belgians 0.092 –2.698 Libert et al. 1998
Table I Comparison of frequencies of CCR5D32 allele in the Serbian population and other European populations.
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Spain Murcia 0.095 –2.067 Libert et al. 1998
Spain Murcia 0.095 –2.067 Faure et al. 2008
Spain Oviedo 0.096 –2.454 Faure et al. 2008
Ukraine Lvov 0.096 –1.679 Faure et al. 2008
Spain Spanish 0.098 –1.379 Stephens et al. 1998
France Montpellier 0.099 –2.818 Faure et al. 2008
Netherlands 0.100 –2.755 Faure et al. 2008
France Montpellier 0.101 –2.095 Libert et al. 1998
Czechia Czechs 0.102 –2.344 Stephens et al. 1998
Hungary Hungarians 0.104 –3.029 Faure et al. 2008
Norway Norwegians 0.105 –2.403 Libert et al. 1998
Germany Mulheim 0.106 –2.095 Faure et al. 2008
Czechia 0.107 –3.303 Faure et al. 2008
Lithuania Vilnius 0.107 –2.926 Faure et al. 2008
France Lille 0.108 –2.374 Faure et al. 2008
Germany Germans 0.108 –2.742 Faure et al. 2008
Denmark Danes 0.110 –2.403 Libert et al. 1998
France Brittany 0.110 –2.403 Libert et al. 1998
Ukraine Kiev 0.110 –2.218 Faure et al. 2008
France Nancy 0.111 –3.098 Faure et al. 2008
Hungary Budapest 0.111 –2.240 Magierowska et al. 1998
Great Britain Brits 0.115 –3.685 Faure et al. 2008
Lithuania Lithuanians 0.115 –3.340 Libert et al. 1998
Finland Finns 0.116 –3.381 Faure et al. 2008
Great Britain British 0.117 –3.529 Stephens et al. 1998
Denmark Danes 0.118 –3.574 Faure et al. 2008
Poland 0.118 –3.935 Faure et al. 2008
Belgium Leuven 0.119 –3.496 Faure et al. 2008
Norway Oslo 0.120 –3.194 Faure et al. 2008
Russia Ryazan 0.120 –2.388 Faure et al. 2008
Russia Tatar 0.120 –2.169 Stephens et al. 1998
France Paris 0.122 –3.657 Faure et al. 2008
France Brest 0.123 –3.298 Faure et al. 2008
Estonia Estonians 0.133 –3.521 Stephens et al. 1998
Russia Russians 0.136 –2.694 Stephens et al. 1998
Sweden Swedish 0.137 –3.512 Stephens et al. 1998
Norway Oslo 0.138 –2.958 Magierowska et al. 1998
Russia Moscow 0.138 –3.459 Faure et al. 2008
Russia Russians 0.139 –3.310 Libert et al. 1998
Slovakia 0.140 –4.305 Faure et al. 2008
Sweden Stockholm 0.140 –4.105 Faure et al. 2008
Sweden Umea 0.142 –4.029 Libert et al. 1998
Sweden Stockholm 0.143 –3.243 Magierowska et al. 1998
Estonia 0.144 –4.761 Faure et al. 2008
Iceland 0.147 –3.582 Faure et al. 2008
Poland Poznan 0.155 –3.236 Magierowska et al. 1998
Finland Finns 0.158 –3.720 Libert et al. 1998
Belarus Belarusians 0.160 –3.776 Faure et al. 2008
Russia Mordvinians 0.163 –3.862 Libert et al. 1998
Russia St. Petersburg 0.166 –2.565 Magierowska et al. 1998
Frequencies of CCR5D32 allele in various European populations. Z values that reach statistical significance using a 95% con-
fidence level are written in bold. Data are taken from the papers indicated under the references.
lator (CFTR), including F508del, 5T and M470V, dif-
fers significantly in the Serbian population in compa ri -
son with other South European populations (19–21).
It would be important to obtain data on the frequen-
cy of the CCR5D32 allele in Bosnia, Herzegovina,
Monte negro and Macedonia to get further insight
into the ethno-geographical relation of the CCR5D32
allele frequency in southeastern Europe.
Finally, besides the importance that our results
have for studies of the origin and spread of CCR5D32
allele in European populations, they are also impor-
tant for cli nical practice. It has recently been reported
that the cure of HIV has been achieved in a patient
grafted with CCR5D32/D32 stem cells (22). Thus,
low frequency of CCR5D32 homozygous individuals
indicates that there will be less potential donors of
CCR5D32/D32 stem cells in the Serbian population.
The ethnical map of Europe is even more com-
plex than its political map and there has been inten-
sive blending of European populations (both within
the continent and with populations from other conti-
nents) due to vivid historical events and processes
(migrations, assimilations, international marriages).
Thus, further determination of CCR5D32 frequency
in various regions and ethnic groups of Europe and
analysis of data so obtained in conjunction with geo-
graphical and historical facts are needed in order to
construct a definitive map of the CCR5D32 allele fre-
quency in Europe. Further, intensive studies of ancient
DNA are imposed. Finally, the CCR5D32 allele fre-
quency has to be investigated in parallel with hap-
logroup analyses. Only then we might be able to give
answers on the origin and spread of the allele in the
European population.
In conclusion, CCR5D32 frequency is relatively
low in the Serbian population in comparison to other
Slavic nations. Yet, it is similar to the frequencies de -
termined in some populations of southern and south -
 eastern Europe.
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